Donna Gievers Zuniga, DPM
Podiatrist · Olney, MDNPI 1659349611
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,924 of the $2,359 with a category attached, or 81.6%. 26 manufacturers reported payments, led by Sunovion Pharmaceuticals Inc. at 34.4% of the total. Reporting peaked in 2023 at $686 and has fallen 90.3% since, to $67 in 2025.
Across 99 payments — averaging $23.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sunovion Pharmaceuticals Inc.$811
- DJO, LLC$434
- Vifor Pharma, Inc.$277
- Amgen$115
- Sumitomo Pharma America, Inc.$94
- Nevro Corp.$81
- plus $546 from 20 others
What the payments were for
- Food & beverage$1,92482%
- Other$43418%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sunovion Pharmaceuticals Inc. | 44 | $811 |
| DJO, LLC | 1 | $434 |
| Vifor Pharma, Inc. | 11 | $277 |
| Amgen | 6 | $115 |
| Sumitomo Pharma America, Inc. | 4 | $94 |
| Nevro Corp. | 3 | $81 |
| Kerecis Limited | 3 | $66 |
| Averitas Pharma Inc. | 2 | $47 |
| Sebela Pharmaceuticals Inc. | 3 | $45 |
| Bayer | 2 | $44 |
| Triad Life Sciences Inc. | 1 | $37 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $34 |
| Novo Nordisk | 2 | $34 |
| Melinta Therapeutics, LLC | 2 | $31 |
| Tactile Systems Technology Inc | 2 | $28 |
| Calliditas Therapeutics US Inc. | 1 | $23 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 1 | $21 |
| Novartis | 1 | $21 |
| Alfasigma USA, Inc. | 1 | $20 |
| Treace Medical Concepts, Inc. | 1 | $17 |
| Organogenesis Inc. | 1 | $15 |
| Zimmer Biomet | 1 | $15 |
| Paratek Pharmaceuticals, Inc. | 1 | $15 |
| Normatec Industries, LP | 1 | $11 |
| Merck | 1 | $11 |
| Musculoskeletal Transplant Foundation Inc. | 1 | $11 |
How this compares
$2,359 in reported general payments places this provider in the 70th percentile of 183 podiatrist providers in Maryland.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ketoconazole | 139 | $3,639 |
| Mupirocin | 52 | $481 |
| CiclopiroxCiclopirox Olamine | 32 | $397 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 12 | $207 |
| Atorvastatin Calcium | 11 | $205 |
| Ammonium Lactate | 11 | $171 |
| Cephalexin | 18 | $131 |
| Famotidine | 11 | $45 |
Paid to pharmacies, not to this prescriber.
Other podiatrist in Olney
- Ijeoma NwujuBethesda$601K
- David Linla Plata$75K
- Ira GottliebPasadena$25K
- Teresa HilliardHyattsville$19K
- Andreas KaikisHagerstown$17K
- Tiffany HohBaltimore$17K
- Shashank SrivastavaFrederick$15K
- Hayden HofflerCatonsville$15K
- Enzo LeonePasadena$15K
- Holly BeckSilver Spring$15K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.